Adenovirus Serotype 5 (Ad5) neutralizing antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenovirus Serotype 5 (Ad5) neutralizing antibodies, covering 2016-02-02 to 2016-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection [NA]